Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypogammaglobulinemia and Immunization Responses to Measles in Rituximab-treated Multiple Sclerosis Patients

NCT04283747 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.

NCT NCT04283747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04283747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypogammaglobulinemia and Immunization Responses to Measles in Rituximab-treated Multiple Sclerosis Patients
Lead sponsor
Mazandaran University of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2020
Completion date
December 31, 2022
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogammaglobulinemia, multiple sclerosis